Community drug expenditure and recent cost containment measures

Hdl Handle:
http://hdl.handle.net/10147/270473
Title:
Community drug expenditure and recent cost containment measures
Authors:
Walshe, V; Kenneally, M
Affiliation:
Health Service Executive (HSE)
Publisher:
Irish Medical Journal
Journal:
Irish Medical Journal
Issue Date:
Feb-2013
URI:
http://hdl.handle.net/10147/270473
Item Type:
Article
Language:
en
Description:
The annual cost of medicines under the community drugs schemes increased from 564m in 2000 to 1,961m in 2009 before falling an estimated 8% by 2011. Escalating public health costs, fiscal stress and the unsustainability of the previous growth in expenditure has led to the increased use of pharmaceutical cost containment measures in Ireland. Collectively, these measures are estimated to have reduced public expenditure on community drugs by 380m in 2011 and involve addressing; 1) the ex-factory price of drugs including price cuts of up to 40% on off-patent and generic drugs leading to an estimated 200m saving (53%); 2) pharmacy dispensing fees and mark-ups via a new dispensing fee structure and reducing both retail and wholesale mark-ups with a 100m saving (26%); and 3) scheme coverage and patient co-payments including restricting scheme coverage for persons over 70 years and increasing the level of co-payments with savings of 80m (21%).
Keywords:
COMMUNITY HEALTH; DRUGS; FINANCE
Local subject classification:
COMMUNITY DRUGS SCHEME

Full metadata record

DC FieldValue Language
dc.contributor.authorWalshe, Ven_GB
dc.contributor.authorKenneally, Men_GB
dc.date.accessioned2013-02-26T12:14:52Z-
dc.date.available2013-02-26T12:14:52Z-
dc.date.issued2013-02-
dc.identifier.urihttp://hdl.handle.net/10147/270473-
dc.descriptionThe annual cost of medicines under the community drugs schemes increased from 564m in 2000 to 1,961m in 2009 before falling an estimated 8% by 2011. Escalating public health costs, fiscal stress and the unsustainability of the previous growth in expenditure has led to the increased use of pharmaceutical cost containment measures in Ireland. Collectively, these measures are estimated to have reduced public expenditure on community drugs by 380m in 2011 and involve addressing; 1) the ex-factory price of drugs including price cuts of up to 40% on off-patent and generic drugs leading to an estimated 200m saving (53%); 2) pharmacy dispensing fees and mark-ups via a new dispensing fee structure and reducing both retail and wholesale mark-ups with a 100m saving (26%); and 3) scheme coverage and patient co-payments including restricting scheme coverage for persons over 70 years and increasing the level of co-payments with savings of 80m (21%).en_GB
dc.language.isoenen
dc.publisherIrish Medical Journalen_GB
dc.subjectCOMMUNITY HEALTHen_GB
dc.subjectDRUGSen_GB
dc.subjectFINANCEen_GB
dc.subject.otherCOMMUNITY DRUGS SCHEMEen_GB
dc.titleCommunity drug expenditure and recent cost containment measuresen_GB
dc.typeArticleen
dc.contributor.departmentHealth Service Executive (HSE)en_GB
dc.identifier.journalIrish Medical Journalen_GB
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.